Pharmaceutical major Dr Reddy's Laboratories (DRL) will be announcing its quarterly results today. The stock has been an outperformer. It is up 28 percent on a year-to-date basis. In comparison, the Nifty is up around 12-13 percent.
In terms of the earnings expectations, the revenue growth is expected to be around 5.6 percent, margins are likely to be stable at around 22 percent with profit at around Rs 481 crore.
CNBC-TV18’s Ekta Batra explains what the Street is expecting this time from the company